Dapagliflozin (461432-26-8)
Specifications
CAS::
461432-26-8
Specification:
CP, EP, In-house, As Required
M.F.:
C21H25ClO6
M.W.:
408.88
Assay:
99%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Dapagliflozin 461432-26-8
,Dapagliflozin API Diabetics
,CAS: 461432-26-8 Dapagliflozin API
Introduction
Dapagliflozin is the first approved SGLT2 inhibitor for the treatment of type II diabetes, which is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.
Product Name: | Dapagliflozin |
CAS No.: | 461432-26-8 |
Assay: | 99% |
Specification: | CP, EP, In-house, as required |
Molecular Formula: | C21H25ClO6 |
Molecular Weight: | 408.88 |
Shelf Life: | 2 Years |
Package: | 25kg/drum |
Related Products
Dapagliflozin Tetraacetate (461432-25-7)
CAS: 461432-25-7; Dapagliflozin manufaturer; Dapagliflozin intermediate; Diabetics
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene (1103738-29-9)
CAS: 1103738-29-9; Dapagliflozin manufaturer; Dapagliflozin intermediate; Diabetics
5-bromo-2-chloro-4'-ethoxydiphenylmethane (461432-23-5)
CAS: 461432-23-5; Dapagliflozin manufaturer; Dapagliflozin intermediate; Diabetics
Image | Part # | Description | |
---|---|---|---|
Dapagliflozin Tetraacetate (461432-25-7) |
CAS: 461432-25-7; Dapagliflozin manufaturer; Dapagliflozin intermediate; Diabetics
|
||
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene (1103738-29-9) |
CAS: 1103738-29-9; Dapagliflozin manufaturer; Dapagliflozin intermediate; Diabetics
|
||
5-bromo-2-chloro-4'-ethoxydiphenylmethane (461432-23-5) |
CAS: 461432-23-5; Dapagliflozin manufaturer; Dapagliflozin intermediate; Diabetics
|
Send RFQ
Stock:
In Stock
MOQ: